Hyaluronidase recombinant human

N/A

Report date: 2024/09/30 20:00:32

Base Information

Drug NameHyaluronidase recombinant human
Drug Alias NameHyaluronidase-fihj重组人透明质酸酶Hyaluronidase-oyskHyaluronidase-zzxfHylenex recombinant +[7] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionHyaluronic acid modulators
TargetsHyaluronic acid
Therapy Area/IndicationsOphthalmologic surgical proceduresContrast agentsScleroderma, Systemic +[18] 
Global Approved IndicationsContrast agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/12/02
Country/TerritoryCanadaUnited StatesSweden +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesHalozyme Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins UniversityBristol-Myers Squibb CompanyHalozyme Therapeutics Inc
Inactive CompaniesShireSuzhou Ruian Biotechnology Co LtdThe Brigham and Women's Hospital +[7] 
Active IndicationsContrast agentsMuscle Spasticity
Inactive IndicationsOphthalmologic surgical proceduresScleroderma, SystemicScleroderma, Localized +[16] 

Other Information

ATC CodeN/A
Related LinksN/A